Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Tralokinumab for atopic dermatitis may cause side effects like dizziness, headache, nausea, hair loss, and acne.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

New topical antifungals and delivery systems are improving treatment for fungal skin infections, but patient education and prevention are key.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Transethosomal gels improve naftifine skin delivery better than Exoderil cream.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

A girl with a rare skin condition improved after one month of treatment with acitretin.

Selamectin effectively cured the cats' infestation.

Posaconazole is a promising new treatment for toenail fungus.

PRP is more effective than triamcinolone for treating alopecia areata.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Low-dose oral naltrexone may help reduce inflammation in some scarring alopecia patients.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Acitretin effectively prevented skin cancer in a patient with late-onset Rothmund-Thomson syndrome.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.